Mottola Frank bought SUPN
December 19, 2025 · Form 4 insider transaction
Mottola Frank bought 15,000 shares of Supernus Pharmaceuticals, Inc. at $25.30 per share, a transaction worth $379.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$25.30
Total value
$379.5K
InsiderMottola Frank
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 19, 2025
Filing dateDecember 22, 2025
Shares owned after30,496
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025.